| __timestamp | Amneal Pharmaceuticals, Inc. | Pfizer Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 106735000 | 8393000000 |
| Thursday, January 1, 2015 | 136870000 | 7690000000 |
| Friday, January 1, 2016 | 204747000 | 7872000000 |
| Sunday, January 1, 2017 | 191938000 | 7657000000 |
| Monday, January 1, 2018 | 210451000 | 8006000000 |
| Tuesday, January 1, 2019 | 202287000 | 8650000000 |
| Wednesday, January 1, 2020 | 190585000 | 9405000000 |
| Friday, January 1, 2021 | 209563000 | 13829000000 |
| Saturday, January 1, 2022 | 200046000 | 11428000000 |
| Sunday, January 1, 2023 | 167778000 | 10679000000 |
| Monday, January 1, 2024 | 10930000000 |
Cracking the code
In the ever-evolving world of pharmaceuticals, research and development (R&D) spending is a key indicator of a company's commitment to innovation. Over the past decade, Pfizer Inc. and Amneal Pharmaceuticals, Inc. have demonstrated contrasting approaches to R&D investment. From 2014 to 2023, Pfizer's R&D expenses have consistently dwarfed those of Amneal, with Pfizer investing nearly 50 times more in 2021 alone. This substantial investment has allowed Pfizer to maintain its position as a leader in the industry, particularly evident in 2021 when their R&D spending peaked at approximately $13.8 billion. In contrast, Amneal's R&D expenses have remained relatively stable, peaking at around $210 million in 2018. This disparity highlights the different scales and strategies of these companies, with Pfizer focusing on large-scale innovation and Amneal maintaining a more conservative approach.
Analyzing R&D Budgets: Novartis AG vs Amneal Pharmaceuticals, Inc.
Comparing Innovation Spending: Pfizer Inc. and Insmed Incorporated
Research and Development: Comparing Key Metrics for Pfizer Inc. and MorphoSys AG
Research and Development: Comparing Key Metrics for Pfizer Inc. and MannKind Corporation
Who Prioritizes Innovation? R&D Spending Compared for Pfizer Inc. and Travere Therapeutics, Inc.
Bristol-Myers Squibb Company or Amneal Pharmaceuticals, Inc.: Who Invests More in Innovation?
Research and Development Expenses Breakdown: Genmab A/S vs Amneal Pharmaceuticals, Inc.
Analyzing R&D Budgets: Grifols, S.A. vs Amneal Pharmaceuticals, Inc.
Amneal Pharmaceuticals, Inc. or Ultragenyx Pharmaceutical Inc.: Who Invests More in Innovation?
Research and Development Expenses Breakdown: Amneal Pharmaceuticals, Inc. vs Geron Corporation
R&D Insights: How Amneal Pharmaceuticals, Inc. and Dynavax Technologies Corporation Allocate Funds
Analyzing R&D Budgets: Amneal Pharmaceuticals, Inc. vs Galapagos NV